Skip to main content

Published locations for Acalabrutinib may outperform other targeted therapies in MCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Acalabrutinib may outperform other targeted therapies in MCL

User login

  • Reset your password
  • /content/acalabrutinib-may-outperform-other-targeted-therapies-mcl
  • /hematologynews/article/213537/mantle-cell-lymphoma/acalabrutinib-may-outperform-other-targeted
  • /oncologypractice/article/213537/mantle-cell-lymphoma/acalabrutinib-may-outperform-other-targeted
  • /hematology-oncology/article/213537/mantle-cell-lymphoma/acalabrutinib-may-outperform-other-targeted
  • /b-cell-lymphoma-icymi/article/213537/mantle-cell-lymphoma/acalabrutinib-may-outperform-other